The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dominant-negative PD1-armored CART cells induce remission in refractory diffuse large B-cell lymphoma (DLBCL) patients.
 
Tong Chen
No Relationships to Disclose
 
Yan Yuan
No Relationships to Disclose
 
Liansheng Huang
No Relationships to Disclose
 
Chengfei Pu
Employment - Innovative Cellular Therapeutics Co
Research Funding - Innovative Cellular Therapeutics Co
Patents, Royalties, Other Intellectual Property - Innovative Cellular Therapeutics Co
 
Tianling Ding
No Relationships to Disclose
 
Xibin Xiao
No Relationships to Disclose
 
Zhiyuan Cao
Employment - Innovative Cellular Therapeutics Co
Research Funding - Innovative Cellular Therapeutics Co
Patents, Royalties, Other Intellectual Property - Innovative Cellular Therapeutics Co
 
Ting Wu
No Relationships to Disclose
 
Luying Ding
No Relationships to Disclose
 
He Sun
Employment - Innovative Cellular Therapeutics Co
Research Funding - Innovative Cellular Therapeutics Co
Patents, Royalties, Other Intellectual Property - Innovative Cellular Therapeutics Co
 
Zhao Wu
Employment - Innovative Cellular Therapeutics Co
Leadership - Innovative Cellular Therapeutics Co
Stock and Other Ownership Interests - Innovative Cellular Therapeutics Co
Research Funding - Innovative Cellular Therapeutics Co
Patents, Royalties, Other Intellectual Property - Innovative Cellular Therapeutics Co
Travel, Accommodations, Expenses - Innovative Cellular Therapeutics Co
 
Lei Xiao
Employment - Innovative Cellular Therapeutics Co
Leadership - Innovative Cellular Therapeutics Co
Stock and Other Ownership Interests - Innovative Cellular Therapeutics Co
Honoraria - Innovative Cellular Therapeutics Co
Patents, Royalties, Other Intellectual Property - Innovative Cellular Therapeutics Co
Travel, Accommodations, Expenses - Innovative Cellular Therapeutics Co
 
Xiaohong Zhang
No Relationships to Disclose